TBCE and metabolic disease: Collectively, hepatic macrophages (BM-MΦ, BM-KCs, KCs) augment metabolic disease during NASH; hepatic steatosis, insulin resistance, and oral glucose tolerance improve in mice with fibrotic NASH following depletion of hepatic macrophages (64, 74–76).